Humboldt Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
32
- Portfolio
-
22
- Exits
-
7
Humboldt Fund General Information
Company Description
Founded in 2020, Humboldt Fund is a venture capital firm based in New York. The firm seeks to invest in food, healthcare, materials, energy, molecular biology, biomaterials, genetics, mechanical engineering, and related sectors.
Business Details
Website
www.humboldtfund.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 477 Madison Avenue
- 6th Floor
- New York, NY 10022
- United States
Humboldt Fund Investments (32)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Momentum Therapeutics (Biotechnology) | 01-Mar-2026 | Early Stage VC | Biotechnology | Startup | ||
| Revr | 22-Sep-2023 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Spiral Therapeutics | 07-Feb-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Metagenomi Therapeutics | 05-Jan-2023 | Drug Discovery | Generating Revenue | |||
| Concerto Biosciences | 02-Nov-2022 | Biotechnology | Clinical Trials - Phase 1 | |||
| Theonys | 16-Aug-2022 | Drug Discovery | Out of Business | |||
| Endpoint Health | 13-Jun-2022 | Drug Discovery | Pre-Clinical Trials | |||
| Affini-T | 17-Mar-2022 | Drug Discovery | Out of Business | |||
| Finless Foods | 07-Mar-2022 | Later Stage VC | Food Products | Generating Revenue | ||
| HAYA Therapeutics | 09-Feb-2022 | Seed Round | Drug Discovery | Clinical Trials - Phase 1 |
Humboldt Fund Exits (7)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Affini-T | 10-Oct-2026 | Out of Business | |
| MycoWorks | 30-Jan-2026 | ||
| Meatable | 19-Dec-2025 | ||
| Metagenomi Therapeutics | 09-Feb-2024 | ||
| Theonys | 17-Oct-2023 | ||
| Miroculus | 15-Mar-2023 | Merger/Acquisition | |
| Finch Therapeutics | 19-Mar-2021 | IPO |
Humboldt Fund Investments by Industry, Year, and Region
Humboldt Fund Co-Investors (133)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Catalio Capital Management | 3 |
|
|
||
| Leaps by Bayer |
|
|
|||
| 8VC |
|
|
|||
| Gaingels |
|
|
|||
| Olive Tree Capital |
|
|
Humboldt Fund FAQs
-
What is Humboldt Fund?
Founded in 2020, Humboldt Fund is a venture capital firm based in New York.
-
When was Humboldt Fund founded?
Humboldt Fund was founded in 2020.
-
Where is Humboldt Fund headquartered?
Humboldt Fund is headquartered in New York, NY.
-
How many investments has Humboldt Fund made?
Humboldt Fund has made 32 investments.
-
What has Humboldt Fund invested in?
Humboldt Fund has made numerous investments in companies like Momentum Therapeutics (Biotechnology), Revr, and Spiral Therapeutics within the Biotechnology, Discovery Tools (Healthcare), and Drug Discovery industries.
-
What has Humboldt Fund invested in recently?
Humboldt Fund's latest investment was on 01-Mar-2026 in Momentum Therapeutics (Biotechnology), a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process